Nitazene Synthetic Opioids Spreading in Midwest Drug Supply: What to Know About Overdose Response

Drug-checking programs and forensic laboratories operating across the Midwest have reported a sustained increase in nitazene-class synthetic opioids appearing in counterfeit pills, powders sold as heroin, and adulterated fentanyl. The pattern aligns with earlier warnings issued through the CDC Health Alert Network and is consistent with what the National Drug Early Warning System (NDEWS) has been tracking in regional academic reports.

If you or someone you know uses opioids that may come from the illicit supply, the practical takeaways are specific. None of them require panic. All of them are worth knowing.

What Nitazenes Are

Nitazenes are a class of synthetic opioids — chemical relatives of older research compounds that were never approved for medical use. They include compounds such as isotonitazene, metonitazene, etonitazene, and protonitazene, among others. Some of these compounds have been reported in the scientific literature to be substantially more potent than fentanyl on a per-milligram basis. Potency varies significantly across the class and between batches.

Like fentanyl, they bind to the same opioid receptors that cause respiratory depression and overdose death. Unlike older heroin or prescription opioids, nitazenes are not typically detected on routine urine drug screens, which can complicate clinical care after an overdose.

What is appearing in the Midwest supply is not new chemically — the first major U.S. nitazene seizures were reported by federal agencies several years ago — but the geographic spread and the product types (counterfeit oxycodone, counterfeit benzodiazepines, and adulterated heroin) reflect a shift in how the supply is being delivered to people who may not realize they are taking a high-potency synthetic opioid.

What Naloxone Does — and Doesn't

This is the most important clinical point and the one most often misstated.

Naloxone (Narcan) does reverse nitazene-involved overdose. Nitazenes are opioids. They act on the same mu-opioid receptors that naloxone is designed to block.

But two practical caveats matter:

• More doses may be required. With high-potency synthetic opioids, a single intranasal dose of naloxone may not be enough. If the person is not breathing adequately or remains unresponsive after one dose, give a second dose two to three minutes later. If multiple doses are available, give a third if needed. Continue rescue breathing between doses.
• Re-narcotization is a real risk. Because some nitazenes have a longer half-life than naloxone, the person can begin to overdose again as the naloxone wears off — even after they have woken up. This is why calling 911 is part of every overdose response, even if the person initially recovers.

The American Society of Addiction Medicine and the CDC have both emphasized in advisories that the existence of more potent opioids in the supply does not mean naloxone has stopped working. It means naloxone needs to be available in larger quantities, used with rescue breathing, and followed by professional medical care.

Signs of a Nitazene-Involved Overdose

These look like other opioid overdoses, with a few features that may be more pronounced:

• Unresponsiveness — the person cannot be woken by shouting or sternum rub.
• Slow or stopped breathing — fewer than 8 breaths per minute, or no breathing at all.
• Pinpoint pupils.
• Blue or grayish lips, fingertips, or skin.
• Choking or gurgling sounds — sometimes called the "death rattle," indicating airway obstruction.
• Rapid onset — with high-potency synthetics, overdose can develop within minutes of use rather than over a longer window.

The combination of rapid onset and severity is what makes nitazene-involved overdoses dangerous. The response window is shorter than with older opioids, and the dose of naloxone needed is often higher.

What to Do If Someone Stops Breathing

The sequence is the same as for any suspected opioid overdose:

1. Call 911. State that you suspect an opioid overdose. Most U.S. states have Good Samaritan laws that protect people calling 911 in an overdose from prosecution for simple possession.
2. Give naloxone if available. One intranasal spray in one nostril, or one intramuscular injection per package instructions.
3. Begin rescue breathing. Tilt the head back, lift the chin, and give one breath every five seconds. Watch for chest rise.
4. If no response in 2–3 minutes, give a second dose of naloxone. Continue rescue breathing.
5. Continue naloxone every 2–3 minutes if breathing does not resume, until emergency services arrive or the person is breathing on their own.
6. Stay with the person. Even after they wake up, the risk of re-narcotization persists. Do not leave them alone until EMS arrives.

If the person resumes breathing but is still groggy, place them in the recovery position — on their side with the upper knee bent forward and the head supported. This reduces the risk of aspiration if they vomit. Continue to monitor breathing.

Where to Get Naloxone

Naloxone is available in all 50 states. The most common access points:

• Pharmacies. All 50 states have standing orders or pharmacist-prescribing arrangements that allow naloxone to be dispensed without an individual prescription. Most insurance plans, including Medicaid, cover the cost. Ask the pharmacist for "Narcan" or generic naloxone nasal spray.
• Local health departments and harm reduction programs. Many distribute naloxone free of charge along with training on use. Search your county's public health website for "naloxone distribution."
• NEXT Distro (nextdistro.org) — a national mail-order harm reduction program that ships naloxone free to most U.S. addresses.
• SAMHSA's National Helpline — 1-800-662-HELP (4357), free and confidential, 24/7, available in English and Spanish, can refer to local resources.

Having two doses available is a baseline. Having four to six doses is more aligned with the potency profile of the current synthetic opioid supply, particularly if more than one person uses opioids in the household or close circle.

Drug Checking and the Supply

People who use drugs are not always in a position to choose what is in the supply. But where local programs offer fentanyl test strips or, in some jurisdictions, more sophisticated drug-checking services (including liquid chromatography or FTIR analysis), using them is one of the only practical tools available to reduce risk before use.

Fentanyl test strips will not directly detect all nitazenes — the strips are calibrated for fentanyl analogs. However, in a supply where fentanyl and nitazenes commonly co-occur, a positive fentanyl strip is still a useful warning that the product is not what it was sold as. Several state harm reduction programs are working toward broader-spectrum strips that can detect multiple synthetic opioid classes.

If you use any opioid from an unregulated source — pressed pills, powders, anything not directly from a pharmacy — assume it may contain synthetic opioids stronger than what was intended. The practical implications are the same: use with someone else present who can respond if needed, start with a smaller-than-usual amount, and have naloxone within reach.

Where to Get Help

If you or someone you love is using opioids and wants to consider treatment options:

• SAMHSA's National Helpline: 1-800-662-HELP (4357). Free, confidential, 24/7.
• 988 — the federal suicide and crisis line — also handles substance use crises and can connect callers with local resources.
• SAMHSA's Find Treatment (findtreatment.gov) — a searchable directory of accredited treatment facilities by ZIP code.

Medication-assisted treatment with buprenorphine, methadone, or naltrexone is the most effective intervention available for opioid use disorder. The federal expansion of telehealth buprenorphine prescribing — which has continued through 2026 under DEA's most recent rulemaking — has made starting treatment substantially more accessible in many parts of the country.

You do not have to be ready for residential treatment to start somewhere. A primary care visit, a phone call to a helpline, or a conversation with a harm reduction program is a legitimate first step. Each of those steps reduces the risk of the worst outcome.